312 related articles for article (PubMed ID: 30242969)
1. Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.
Yang Y; Qu A; Zhao R; Hua M; Zhang X; Dong Z; Zheng G; Pan H; Wang H; Yang X; Zhang Y
Mol Oncol; 2018 Dec; 12(12):2072-2084. PubMed ID: 30242969
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.
Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A
Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841
[No Abstract] [Full Text] [Related]
3. Plasma microRNA-based signatures to predict 3-year postoperative recurrence risk for stage II and III gastric cancer.
Liu X; Zhang X; Zhang Z; Chang J; Wang Z; Wu Z; Wang C; Sun Z; Ge X; Geng R; Tang W; Dai C; Lin Y; Lin F; Sun M; Jia W; Xue W; Ji J; Hu Y; Qin G; Li J
Int J Cancer; 2017 Nov; 141(10):2093-2102. PubMed ID: 28722210
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of a hypoxia-related microRNA signature in patients with colorectal cancer.
Yang Y; Qu A; Wu Q; Zhang X; Wang L; Li C; Dong Z; Du L; Wang C
Aging (Albany NY); 2020 Jan; 12(1):35-52. PubMed ID: 31926112
[TBL] [Abstract][Full Text] [Related]
5. Recurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancer.
Tian X; Zhu X; Yan T; Yu C; Shen C; Hu Y; Hong J; Chen H; Fang JY
Mol Oncol; 2017 Nov; 11(11):1544-1560. PubMed ID: 28796930
[TBL] [Abstract][Full Text] [Related]
6. Identification and external validation of a novel miRNA signature for lymph node metastasis prediction in submucosal-invasive gastric cancer patients.
Ma M; Lu S; Liu Y; Kong P; Long Z; Wan P; Zhang Y; Wang Y; Xu D
Cancer Med; 2019 Oct; 8(14):6315-6325. PubMed ID: 31486298
[TBL] [Abstract][Full Text] [Related]
7. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
[TBL] [Abstract][Full Text] [Related]
9. A six-microRNA signature to predict outcomes of patients with gastric cancer.
Chen J; Hu B; Wang W; Qian XJ; Shan BJ; He YF
FEBS Open Bio; 2019 Mar; 9(3):538-547. PubMed ID: 30868062
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients.
Chen W; Yu Q; Chen B; Lu X; Li Q
Oncotarget; 2016 Aug; 7(33):53392-53413. PubMed ID: 27438144
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and Prognostic Value of Serum MicroRNA-206 in Patients with Gastric Cancer.
Hou CG; Luo XY; Li G
Cell Physiol Biochem; 2016; 39(4):1512-20. PubMed ID: 27614739
[TBL] [Abstract][Full Text] [Related]
13. A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer.
Peng K; Chen E; Li W; Cheng X; Yu Y; Cui Y; Li Q; Wang Y; Xu X; Tang C; Gan L; Yu S; Liu T
J Cell Physiol; 2020 Jul; 235(7-8):5777-5786. PubMed ID: 32048287
[TBL] [Abstract][Full Text] [Related]
14. MiR 21-5p as a predictor of recurrence in young gastric cancer patients.
Park SK; Park YS; Ahn JY; Do EJ; Kim D; Kim JE; Jung K; Byeon JS; Ye BD; Yang DH; Park SH; Hwang SW; Jung HY; Myung SJ
J Gastroenterol Hepatol; 2016 Aug; 31(8):1429-35. PubMed ID: 26824898
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of microRNA Signature in Patients with Gastric Cancers.
Liu HT; Wang YW; Xing AY; Shi DB; Zhang H; Guo XY; Xu J; Gao P
Sci Rep; 2017 Feb; 7():42806. PubMed ID: 28202938
[TBL] [Abstract][Full Text] [Related]
16. Analysis of microRNA expression profiles reveals a 5‑microRNA prognostic signature for predicting overall survival time in patients with gastric adenocarcinoma.
Zhao R; Zhao L; Xu X; Xu H
Oncol Rep; 2019 May; 41(5):2775-2789. PubMed ID: 30864737
[TBL] [Abstract][Full Text] [Related]
17. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
[TBL] [Abstract][Full Text] [Related]
18. Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling.
Kristensen H; Thomsen AR; Haldrup C; Dyrskjøt L; Høyer S; Borre M; Mouritzen P; Ørntoft TF; Sørensen KD
Oncotarget; 2016 May; 7(21):30760-71. PubMed ID: 27120795
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel microRNA recurrence-related signature and risk stratification system in breast cancer.
Lai J; Chen B; Zhang G; Wang Y; Mok H; Wen L; Pan Z; Su F; Liao N
Aging (Albany NY); 2019 Sep; 11(18):7525-7536. PubMed ID: 31548433
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic significance of aberrant Arpin expression in gastric cancer.
Li T; Zheng HM; Deng NM; Jiang YJ; Wang J; Zhang DL
World J Gastroenterol; 2017 Feb; 23(8):1450-1457. PubMed ID: 28293092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
